BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9499416)

  • 1. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
    Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J
    Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.
    Reiter A; Sohal J; Kulkarni S; Chase A; Macdonald DH; Aguiar RC; Gonçalves C; Hernandez JM; Jennings BA; Goldman JM; Cross NC
    Blood; 1998 Sep; 92(5):1735-42. PubMed ID: 9716603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
    Xiao S; Nalabolu SR; Aster JC; Ma J; Abruzzo L; Jaffe ES; Stone R; Weissman SM; Hudson TJ; Fletcher JA
    Nat Genet; 1998 Jan; 18(1):84-7. PubMed ID: 9425908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13).
    Popovici C; Adélaïde J; Ollendorff V; Chaffanet M; Guasch G; Jacrot M; Leroux D; Birnbaum D; Pébusque MJ
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5712-7. PubMed ID: 9576949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1.
    Popovici C; Zhang B; Grégoire MJ; Jonveaux P; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
    Blood; 1999 Feb; 93(4):1381-9. PubMed ID: 9949182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of four new translocations involving FGFR1 in myeloid disorders.
    Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
    Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
    Walz C; Chase A; Schoch C; Weisser A; Schlegel F; Hochhaus A; Fuchs R; Schmitt-Gräff A; Hehlmann R; Cross NC; Reiter A
    Leukemia; 2005 Jun; 19(6):1005-9. PubMed ID: 15800673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.
    Ollendorff V; Guasch G; Isnardon D; Galindo R; Birnbaum D; Pébusque MJ
    J Biol Chem; 1999 Sep; 274(38):26922-30. PubMed ID: 10480903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins.
    Demiroglu A; Steer EJ; Heath C; Taylor K; Bentley M; Allen SL; Koduru P; Brody JP; Hawson G; Rodwell R; Doody ML; Carnicero F; Reiter A; Goldman JM; Melo JV; Cross NC
    Blood; 2001 Dec; 98(13):3778-83. PubMed ID: 11739186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.
    Grand EK; Grand FH; Chase AJ; Ross FM; Corcoran MM; Oscier DG; Cross NC
    Genes Chromosomes Cancer; 2004 May; 40(1):78-83. PubMed ID: 15034873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene.
    Mugneret F; Chaffanet M; Maynadié M; Guasch G; Favre B; Casasnovas O; Birnbaum D; Pébusque MJ
    Br J Haematol; 2000 Nov; 111(2):647-9. PubMed ID: 11122115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
    Macdonald D; Reiter A; Cross NC
    Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes.
    Belloni E; Trubia M; Gasparini P; Micucci C; Tapinassi C; Confalonieri S; Nuciforo P; Martino B; Lo-Coco F; Pelicci PG; Di Fiore PP
    Genes Chromosomes Cancer; 2005 Mar; 42(3):320-5. PubMed ID: 15609342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
    Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
    Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12.
    Chaffanet M; Popovici C; Leroux D; Jacrot M; Adélaïde J; Dastugue N; Grégoire MJ; Hagemeijer A; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
    Oncogene; 1998 Feb; 16(7):945-9. PubMed ID: 9484786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.
    Murati A; Arnoulet C; Lafage-Pochitaloff M; Adélaide J; Derré M; Slama B; Delaval B; Popovici C; Vey N; Xerri L; Mozziconacci MJ; Boulat O; Sainty D; Birnbaum D; Chaffanet M
    Int J Oncol; 2005 Jun; 26(6):1485-92. PubMed ID: 15870860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
    Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
    Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13.
    Still IH; Cowell JK
    Blood; 1998 Aug; 92(4):1456-8. PubMed ID: 9694738
    [No Abstract]   [Full Text] [Related]  

  • 20. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3).
    Guasch G; Popovici C; Mugneret F; Chaffanet M; Pontarotti P; Birnbaum D; Pébusque MJ
    Blood; 2003 Jan; 101(1):286-8. PubMed ID: 12393597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.